Piperacillin/Tazobactam: A New Beta-Lactam/Beta-Lactamase Inhibitor Combination

doi:10.1177/106002809502900510

Article

Piperacillin/Tazobactam: A New Beta-Lactam/Beta-Lactamase Inhibitor Combination

1 May 1995

Abstract excerpt

OBJECTIVE: To discuss the antimicrobial activity, pharmacokinetics, clinical efficacy, and adverse effect profile of piperacillin/tazobactam, a new beta-lactan/beta-lactamase inhibitor combination. DATA SOURCES: Literature was identified by MEDLINE search of the medical literature, review of selected references, and data provided by the manufacturer. STUDY SELECTION: In vitro susceptibility data were surveyed...

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.